GENELUX Corp SEC filings GNLX

GENELUX Corp has 359 filings in SEC EDGAR's recent list, going back to May 5, 2003. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Jun 22, 2026 (shareholder vote results). The company's fiscal year ends on December 31.

GENELUX Corp SEC filings
Form Description Filed Period
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 4, 2026 —
4 Insider transaction Sep 2, 2026 Aug 31, 2026
4 Insider transaction Sep 2, 2026 Aug 31, 2026
4 Insider transaction Sep 2, 2026 Aug 31, 2026
10-Q Quarterly report Aug 13, 2026 Jun 30, 2026
4 Insider transaction Aug 4, 2026 Aug 4, 2026
4 Insider transaction Aug 4, 2026 Aug 4, 2026
4 Insider transaction Aug 4, 2026 Aug 4, 2026
4 Insider transaction Jul 2, 2026 Jul 1, 2026
144 Notice of proposed sale Jul 1, 2026 —
8-K Current report
Shareholder vote results
Jun 22, 2026 Jun 16, 2026
4 Insider transaction Jun 18, 2026 Jun 16, 2026
4 Insider transaction Jun 18, 2026 Jun 16, 2026
4 Insider transaction Jun 18, 2026 Jun 16, 2026
4 Insider transaction Jun 18, 2026 Jun 16, 2026
4 Insider transaction Jun 18, 2026 Jun 16, 2026
4 Insider transaction Jun 18, 2026 Jun 16, 2026
4 Insider transaction Jun 18, 2026 Jun 16, 2026
4 Insider transaction Jun 18, 2026 Jun 16, 2026
4 Insider transaction Jun 18, 2026 Jun 16, 2026
4 Insider transaction Jun 4, 2026 Jun 3, 2026
4 Insider transaction Jun 2, 2026 Jun 1, 2026
144 Notice of proposed sale Jun 1, 2026 —
4 Insider transaction May 12, 2026 May 11, 2026
4 Insider transaction May 12, 2026 May 11, 2026
4 Insider transaction May 12, 2026 May 11, 2026
4 Insider transaction May 12, 2026 May 11, 2026
10-Q Quarterly report May 7, 2026 Mar 31, 2026
ARS Annual report to shareholders Apr 29, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 29, 2026 —
DEF 14A Proxy statement Apr 29, 2026 Apr 29, 2026
4 Insider transaction Mar 26, 2026 Mar 24, 2026
4 Insider transaction Mar 26, 2026 Mar 24, 2026
4 Insider transaction Mar 26, 2026 Mar 24, 2026
4 Insider transaction Mar 26, 2026 Mar 24, 2026
424B5 Prospectus supplement Mar 19, 2026 —
S-8 Employee stock plan registration Mar 19, 2026 —
8-K Current report
Material agreement
Mar 19, 2026 Mar 19, 2026
10-K Annual report Mar 19, 2026 Dec 31, 2025
4 Insider transaction Mar 3, 2026 Mar 2, 2026
144 Notice of proposed sale Mar 2, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
8-K Current report
Regulation FD disclosure
Feb 2, 2026 Feb 2, 2026
8-K Current report
Other events
Jan 8, 2026 Jan 8, 2026
424B5 Prospectus supplement Jan 8, 2026 —
4 Insider transaction Jan 7, 2026 Jan 2, 2026
3 Initial insider ownership Jan 7, 2026 Jan 2, 2026
424B5 Prospectus supplement Jan 7, 2026 —
8-K Current report
Regulation FD disclosure, Other events
Jan 5, 2026 Jan 5, 2026
8-K Current report
Officer or director change
Jan 2, 2026 Dec 30, 2025
4 Insider transaction Dec 11, 2025 Aug 21, 2025
4 Insider transaction Dec 11, 2025 Aug 21, 2025
4 Insider transaction Dec 11, 2025 Aug 21, 2025
4 Insider transaction Dec 9, 2025 Aug 21, 2025
4 Insider transaction Dec 2, 2025 Dec 1, 2025
144 Notice of proposed sale Dec 1, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Nov 14, 2025 —
10-Q Quarterly report Nov 5, 2025 Sep 30, 2025
4 Insider transaction Sep 3, 2025 Sep 1, 2025
4 Insider transaction Sep 3, 2025 Sep 1, 2025
4 Insider transaction Sep 3, 2025 Sep 1, 2025
4 Insider transaction Sep 3, 2025 Sep 1, 2025
8-K Current report
Officer or director change, Shareholder vote results
Sep 3, 2025 Aug 27, 2025
4 Insider transaction Aug 29, 2025 Aug 27, 2025
4 Insider transaction Aug 29, 2025 Aug 27, 2025
4 Insider transaction Aug 29, 2025 Aug 27, 2025
4 Insider transaction Aug 29, 2025 Aug 27, 2025
4 Insider transaction Aug 29, 2025 Aug 27, 2025
4 Insider transaction Aug 29, 2025 Aug 27, 2025
4 Insider transaction Aug 29, 2025 Aug 27, 2025
4 Insider transaction Aug 29, 2025 Aug 27, 2025
S-8 Employee stock plan registration Aug 7, 2025 —
10-Q Quarterly report Aug 7, 2025 Jun 30, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 25, 2025 —
ARS Annual report to shareholders Jul 11, 2025 Dec 31, 2024
DEFA14A Additional proxy material Jul 11, 2025 —
DEF 14A Proxy statement Jul 11, 2025 Jul 11, 2025
4 Insider transaction Jul 2, 2025 Jul 1, 2025
3 Initial insider ownership Jul 2, 2025 Jul 1, 2025
4 Insider transaction Jun 24, 2025 Jun 6, 2025
4 Insider transaction May 13, 2025 May 12, 2025
4 Insider transaction May 13, 2025 May 12, 2025
4 Insider transaction May 13, 2025 May 12, 2025
4 Insider transaction May 13, 2025 May 12, 2025
4 Insider transaction May 13, 2025 May 12, 2025
10-Q Quarterly report May 6, 2025 Mar 31, 2025
10-K/A Amended annual report Apr 29, 2025 Dec 31, 2024
4 Insider transaction Apr 17, 2025 Mar 14, 2025
4 Insider transaction Apr 17, 2025 Mar 14, 2025
4 Insider transaction Apr 17, 2025 Mar 14, 2025
4 Insider transaction Apr 17, 2025 Mar 14, 2025
4 Insider transaction Apr 17, 2025 Mar 14, 2025
S-8 Employee stock plan registration Mar 28, 2025 —
10-K Annual report Mar 28, 2025 Dec 31, 2024
424B5 Prospectus supplement Mar 25, 2025 —
8-K Current report
Other events
Mar 25, 2025 Mar 25, 2025
FWP Free writing prospectus Mar 25, 2025 —
8-K Current report
Results of operations, Regulation FD disclosure, Other events
Mar 25, 2025 Mar 25, 2025
4 Insider transaction Feb 3, 2025 Jan 31, 2025
3 Initial insider ownership Feb 3, 2025 Jan 30, 2025
8-K Current report
Officer or director change
Feb 3, 2025 Jan 29, 2025
4/A Filing Dec 31, 2024 Aug 1, 2024
4/A Filing Dec 31, 2024 Aug 1, 2024
4/A Filing Dec 31, 2024 Aug 1, 2024
4/A Filing Dec 31, 2024 Aug 1, 2024
4 Insider transaction Dec 30, 2024 Dec 30, 2024
144 Notice of proposed sale Dec 30, 2024 —
4 Insider transaction Dec 20, 2024 Dec 18, 2024
4 Insider transaction Dec 20, 2024 Dec 18, 2024
4 Insider transaction Dec 20, 2024 Dec 18, 2024
4 Insider transaction Dec 20, 2024 Dec 18, 2024
4 Insider transaction Dec 20, 2024 Dec 18, 2024
4 Insider transaction Dec 20, 2024 Dec 18, 2024
4 Insider transaction Dec 18, 2024 Dec 16, 2024
4 Insider transaction Dec 18, 2024 Dec 16, 2024
4 Insider transaction Dec 18, 2024 Dec 16, 2024
4 Insider transaction Dec 18, 2024 Dec 16, 2024
10-Q Quarterly report Nov 14, 2024 Sep 30, 2024
8-K Current report
Regulation FD disclosure
Nov 8, 2024 Nov 8, 2024
SC 13G Ownership over 5% (passive) Oct 25, 2024 —
SC 13G/A Amended ownership over 5% (passive) Oct 22, 2024 —
4 Insider transaction Oct 21, 2024 Oct 18, 2024
8-K Current report
Officer or director change
Oct 3, 2024 Sep 23, 2024
4/A Filing Sep 26, 2024 Sep 11, 2024
4 Insider transaction Sep 13, 2024 Sep 12, 2024
4 Insider transaction Sep 12, 2024 Sep 11, 2024
4 Insider transaction Sep 11, 2024 Sep 9, 2024
144 Notice of proposed sale Sep 11, 2024 —
144 Notice of proposed sale Sep 6, 2024 —
4 Insider transaction Sep 6, 2024 Sep 3, 2024
4 Insider transaction Aug 30, 2024 Aug 28, 2024
4 Insider transaction Aug 27, 2024 Aug 23, 2024
144 Notice of proposed sale Aug 22, 2024 —
10-Q Quarterly report Aug 14, 2024 Jun 30, 2024
8-K Current report
Shareholder vote results
Aug 6, 2024 Aug 1, 2024
4 Insider transaction Aug 5, 2024 Aug 1, 2024
4 Insider transaction Aug 5, 2024 Aug 1, 2024
4 Insider transaction Aug 5, 2024 Aug 1, 2024
4 Insider transaction Aug 5, 2024 Aug 1, 2024
8-K Current report
Regulation FD disclosure
Aug 1, 2024 Aug 1, 2024
4 Insider transaction Jul 8, 2024 Feb 19, 2024
4 Insider transaction Jul 8, 2024 Feb 19, 2024
4 Insider transaction Jul 8, 2024 Feb 19, 2024
4 Insider transaction Jul 8, 2024 Feb 19, 2024
4 Insider transaction Jul 8, 2024 Feb 19, 2024
4 Insider transaction Jul 8, 2024 Feb 19, 2024
4 Insider transaction Jul 8, 2024 Feb 19, 2024
ARS Annual report to shareholders Jun 14, 2024 Dec 31, 2023
DEFA14A Additional proxy material Jun 14, 2024 —
DEF 14A Proxy statement Jun 14, 2024 Jun 14, 2024
4 Insider transaction Jun 7, 2024 May 29, 2024
4 Insider transaction Jun 7, 2024 May 29, 2024
4 Insider transaction Jun 7, 2024 May 29, 2024
4 Insider transaction Jun 7, 2024 May 29, 2024
4 Insider transaction Jun 7, 2024 May 29, 2024
4 Insider transaction Jun 7, 2024 May 29, 2024
4 Insider transaction Jun 7, 2024 May 29, 2024
4 Insider transaction Jun 7, 2024 May 29, 2024
4 Insider transaction Jun 7, 2024 May 29, 2024
8-K Current report
Regulation FD disclosure, Other events
Jun 5, 2024 Jun 3, 2024
424B5 Prospectus supplement May 24, 2024 —
8-K Current report
Material agreement, Regulation FD disclosure, Other events
May 24, 2024 May 23, 2024
424B5 Prospectus supplement May 23, 2024 —
4 Insider transaction May 15, 2024 May 13, 2024
4 Insider transaction May 9, 2024 May 7, 2024
10-Q Quarterly report May 9, 2024 Mar 31, 2024
4 Insider transaction May 1, 2024 Apr 29, 2024
4 Insider transaction Apr 24, 2024 Apr 22, 2024
4 Insider transaction Apr 18, 2024 Apr 16, 2024
144/A Filing Apr 15, 2024 —
144 Notice of proposed sale Apr 11, 2024 —
8-K Current report
Regulation FD disclosure
Apr 9, 2024 Apr 9, 2024
8-K Current report
Regulation FD disclosure
Apr 2, 2024 Apr 1, 2024
S-8 Employee stock plan registration Mar 29, 2024 —
10-K Annual report Mar 29, 2024 Dec 31, 2023
EFFECT Filing Feb 13, 2024 —
CORRESP Letter to the SEC Feb 8, 2024 —
UPLOAD Letter from the SEC Feb 8, 2024 —
8-K Current report
Regulation FD disclosure
Feb 5, 2024 Feb 5, 2024
8-K Current report
Results of operations, Other events
Feb 2, 2024 Feb 2, 2024
S-3 Shelf registration Feb 2, 2024 —
SC 13G Ownership over 5% (passive) Feb 2, 2024 —
4 Insider transaction Dec 18, 2023 Dec 15, 2023
144 Notice of proposed sale Dec 15, 2023 —
4 Insider transaction Dec 14, 2023 Dec 13, 2023
4 Insider transaction Dec 14, 2023 Dec 13, 2023
144 Notice of proposed sale Dec 13, 2023 —
144 Notice of proposed sale Dec 13, 2023 —
8-K Current report
Regulation FD disclosure
Dec 12, 2023 Dec 12, 2023
4 Insider transaction Dec 8, 2023 Dec 7, 2023
144 Notice of proposed sale Dec 7, 2023 —
8-K Current report
Officer or director change
Nov 24, 2023 Nov 21, 2023
4 Insider transaction Nov 22, 2023 Nov 21, 2023
4 Insider transaction Nov 21, 2023 Nov 17, 2023
144 Notice of proposed sale Nov 17, 2023 —
S-8 Employee stock plan registration Nov 15, 2023 —
10-Q Quarterly report Nov 14, 2023 Sep 30, 2023
4 Insider transaction Oct 26, 2023 Oct 25, 2023
4 Insider transaction Oct 25, 2023 Oct 23, 2023
4 Insider transaction Oct 25, 2023 Oct 24, 2023

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
GNLX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Westlake Village, CA
SEC filer status
Non-accelerated filer, Smaller reporting company, Emerging growth company
SEC CIK
1231457

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.